Schweiger M, Hubler M, Albisetti M. Heparin anticoagulation monitoring in patients supported by ventricular assist devices. ASAIO J. 2015;61:487–8.

Article  PubMed  Google Scholar 

Huang JY, Monagle P, Massicotte MP, VanderPluym CJ. Antithrombotic therapies in children on durable ventricular assist devices: a literature review. Thromb Res. 2018;172:194–203.

Article  CAS  PubMed  Google Scholar 

Sylvia LM, Ordway L, Pham DT, DeNofrio D, Kiernan M. Bivalirudin for treatment of LVAD thrombosis: a case series. ASAIO J. 2014;60:744–7.

Article  PubMed  Google Scholar 

Burstein D, Kimmel S, Putt M, Rossano J, VanderPluym C. Cost-effectiveness of bivalirudin in pediatric ventricular assist devices. J Heart Lung Transplant. 2022. https://doi.org/10.1016/j.healun.2022.10.006.

Article  PubMed  Google Scholar 

Rimsans J, Sylvester KW, Connors JM. Direct thrombin inhibitor for LVAD thrombosis: a closer look. Clin Appl Thromb Hemost. 2017;23:405–9.

Article  CAS  PubMed  Google Scholar 

Ryerson LM, Balutis KR, Granoski DA, Nelson LR, Massicotte MP, Lequier LL, et al. Prospective exploratory experience with bivalirudin anticoagulation in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2020;21:975–85.

Article  PubMed  Google Scholar 

Wong TE, Huang YS, Weiser J, Brogan TV, Shah SS. Antithrombin concentrate use in children: a multicenter cohort study. J Pediatr. 2013;163:1329-1334.e1.

Article  CAS  PubMed  Google Scholar 

Bates A, Buchholz H, Freed D, MacArthur R, Pi DT, Conway J. Bivalirudin experience in a heterogeneous ventricular assist device population. ASAIO J. 2020;66:677–82.

Article  CAS  PubMed  Google Scholar 

VanderPluym CJ, Cantor RS, Machado D, Boyle G, May L, Griffiths E, et al. Utilization and outcomes of children treated with direct thrombin inhibitors on paracorporeal ventricular assist device support. ASAIO J. 2020;66:939–45.

Article  CAS  PubMed  Google Scholar 

Puri K, Tunuguntla HP, Hensch LA, Loh J, Hui SK, Razavi A, et al. Bivalirudin or unfractionated heparin for anticoagulation in pediatric patients on continuous flow ventricular assist device support: single-center retrospective cohort study. Pediatr Crit Care Med. 2022;23:e465–75.

Article  PubMed  Google Scholar 

Zaleski KL, DiNardo JA, Nasr VG. Bivalirudin for pediatric procedural anticoagulation: a narrative review. Anesth Analg. 2019;128:43–55.

Article  CAS  PubMed  Google Scholar 

Teruya J, Hensch L, Bruzdoski K, Adachi I, Hui SR. Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: thromboelastometry versus routine coagulation testing. Thromb Res. 2020;186:54–7.

Article  CAS  PubMed  Google Scholar 

Molinaro RJ, Szlam F, Levy JH, Fantz CR, Tanaka KA. Low plasma fibrinogen levels with the clauss method during anticoagulation with bivalirudin. Anesthesiology. 2008;109:160–1.

Article  PubMed  Google Scholar 

Rabinowitz EJ, Ouyang A, Armstrong DR, Wallendorf M. Poor reliability of common measures of anticoagulation in pediatric extracorporeal membrane oxygenation. ASAIO J. 2021;68:850–8.

Article  Google Scholar 

Engel ELM, Martin J, Palumbo J, Lorts A, Geer R, Luchtman-Jones L. Use of bivalirudin-specific monitoring assays in ventricular assist device patients. Blood. 2021;138:3236.

Article  Google Scholar 

Teruya J, Bruzdoski K, Hensch L, Hui SR, Kostousov V. How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-comparison of four assay methods. Int J Lab Hematol. 2022;44:589–94.

Article  PubMed  Google Scholar 

Adatya S, Uriel N, Yarmohammadi H, Holley CT, Feng A, Roy SS, et al. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support. JACC Heart Fail. 2015;3:314–22.

Article  PubMed  Google Scholar 

van Zaane B, Nur E, Squizzato A, Gerdes VE, Buller HR, Dekkers OM, et al. Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost. 2010;8:2483–93.

Article  PubMed  Google Scholar 

Perry T, Bora K, Bakar A, Meyer DB, Sweberg T. Non-surgical risk factors for the development of chylothorax in children after cardiac surgery—does fluid matter? Pediatr Cardiol. 2020;41:194–200.

Article  PubMed  Google Scholar 

Buckley JR, Graham EM, Gaies M, Alten JA, Cooper DS. Clinical epidemiology and centre variation in chylothorax rates after cardiac surgery in children a report from the pediatric cardiac critical care consortium. Cardiol Young. 2017. https://doi.org/10.1017/S104795111700097X.

Article  PubMed  Google Scholar 

Bernet-Buettiker V, Waldvogel K, Cannizzaro V, Albisetti M. Antithrombin activity in children with chylothorax. Eur J Cardiothorac Surg. 2006;29:406–9.

Article  PubMed  Google Scholar 

Zuluaga MT. Chylothorax after surgery for congenital heart disease. Curr Opin Pediatr. 2012;24:291–4.

Article  PubMed  Google Scholar